Login / Signup

Fingolimod-induced bladder lymphoma in a patient with multiple sclerosis.

Saeed VahebElham Moases GhaffaryVahid ShayegannejadOmid Mirmosayyeb
Published in: Clinical case reports (2023)
Fingolimod is a medication with a potential cure to control multiple sclerosis (MS) relapses. Here we describe a 32-year-old woman with relapsing-remitting multiple sclerosis who developed bladder lymphoma induced by long-term use of Fingolimod. Physicians should consider the carcinogenic effects of Fingolimod in long-term use and replace it with safer medicines.
Keyphrases
  • multiple sclerosis
  • white matter
  • diffuse large b cell lymphoma
  • spinal cord injury
  • primary care
  • case report
  • diabetic rats
  • high glucose
  • mass spectrometry
  • rheumatoid arthritis
  • oxidative stress
  • ms ms
  • risk assessment